Normando Iznaga-Escobar

Use of the Humanized Anti-Epidermal Growth Factor Receptor Monoclonal Antibody h-R3 in Combination With Radiotherapy in the Treatment of Locally Advanced Head and Neck Cancer Patients

Tania Crombet, Marta Osorio, Teresa Cruz et al. · Journal of Clinical Oncology · 2004 · 298 citations · Full text

99mTc-labeled antihuman epidermal growth factor receptor antibody in patients with tumors of epithelial origin: Part III. Clinical trials safety and diagnostic efficacy.

Mayra Ramos, Nelson Rodríguez, Juan P. Oliva et al. · PubMed · 1999 · 52 citations

Nimotuzumab and radiotherapy for treatment of newly diagnosed diffuse intrinsic pontine glioma (DIPG): a phase III clinical study

Gudrun Fleischhack, Maura Massimino, Monika Warmuth‐Metz et al. · Journal of Neuro-Oncology · 2019 · 44 citations · Full text

Neuro-oncology, Radiation Therapy, Glioma +10

Construction of an immunotoxin with the pore forming protein StI and ior C5, a monoclonal antibody against a colon cancer cell line

Mayra Tejuca, Isabel Dı́az, René Figueredo et al. · International Immunopharmacology · 2004 · 43 citations

Ior C5, Protein Sti, Immunology +9

Phase I/II clinical trial of the humanized anti-EGF-r monoclonal antibody h-R3 labelled with 99mTc in patients with tumour of epithelial origin

Leonel Torres, Alejandro Perera, Juan F. Batista et al. · Nuclear Medicine Communications · 2005 · 32 citations